Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04278352 · ClinicalTrials.gov registry record · NA
Mindfulness-Based Relapse Prevention for Opioid and Alcohol Use Disorders
A NA study, sponsored by Clemson University.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT04278352 is a NA study that has completed, run by Clemson University. The registered enrollment target is 11 participants.
The verdict
NCT04278352, a NA study, has completed, sponsored by Clemson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
A randomized controlled trial will examine mindfulness-based relapse prevention (MBRP) program outcomes for 240 individuals who have completed treatment for opioid or alcohol use disorders. MBRP is a group aftercare program that integrates mindfulness skills training with cognitive-behavioral relapse prevention strategies. Primary outcomes will include frequency of opioid/alcohol use, craving, withdrawal, and quality of life. Secondary outcomes include time to first opioid/alcohol use, adherence to medication-assisted treatment plans, perceived stress, posttraumatic stress symptoms, and chronic pain. We will also examine the following potential moderators of intervention outcomes: comorbid diagnoses, life events history, and MBRP intervention adherence. In addition, we will examine the following mediators of intervention outcome: mindfulness skills, emotion regulation skills, executive functioning skills, savoring, and positive and negative affect.
Interventions
- BEHAVIORAL Mindfulness Based Relapse Prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2023-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04278352
The ClinicalTrials.gov registry entry for NCT04278352 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clemson University, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mindfulness Based Relapse Prevention is the first listed.
NCT04278352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04278352 about?
NCT04278352 is a clinical study titled "Mindfulness-Based Relapse Prevention for Opioid and Alcohol Use Disorders". A randomized controlled trial will examine mindfulness-based relapse prevention (MBRP) program outcomes for 240 individuals who have completed treatment for opioid or alcohol use disorders. MBRP is a group aftercare program that integrates mindfulness skills training with cognitive-behavioral relaps...
What is the current status of trial NCT04278352?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2020-07-01. Estimated completion is 2023-08-01.
What interventions are being tested in trial NCT04278352?
The interventions under investigation include: Mindfulness Based Relapse Prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04278352?
This trial is sponsored by Clemson University, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.